Abstract
Telemedicine is a viable solution for providing treatment and longitudinal care to patients with Parkinson’s disease. With an expected rise in the national and global burden of neurodegenerative disorders, including Parkinson’s and Alzheimer’s disease, there will be a greater need for neurologic care services which are able to reach individuals despite distance from major care providers. Given the current distribution of specialists, the present standard of care for Parkinson’s disease is insufficient to meet the changing needs of patients. Demand for safe and inexpensive strategies for providing high-quality care to individuals living with Parkinson’s disease will continue to increase. Challenges, especially reimbursement and licensure, still hinder the expanded adoption of telemedicine, yet many of the present barriers will be resolved as states continue to propose and enact legislation in support of telemedicine. We present a model of providing specialty care to patients by using telemedicine that is generalizable to other physicians and institutions and can help to improve care for individuals with Parkinson’s disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- HIPAA:
-
Health Insurance Portability and Accountability Act
- MDS-UPDRS:
-
Movement Disorder Society-Unified Parkinson’s Disease Rating Scale
- OTN:
-
Ontario Telemedicine Network
- UPDRS:
-
Unified Parkinson’s Disease Rating Scale
- VHA:
-
Veterans Health Administration
References
Hubble JP, Pahwa R, Michalek DK, Thomas C, Koller WC. Interactive video conferencing: a means of providing interim care to Parkinson’s disease patients. Mov disord. 1993;8(3):380–2.
Cubo E, Gabriel-Galan JM, Martinez JS, Alcubilla CR, Yang C, Arconada OF, et al. Comparison of office-based versus home Web-based clinical assessments for Parkinson’s disease. Mov disord. 2012;27(2):308–11.
Dorsey ER, Deuel LM, Voss TS, Finnigan K, George BP, Eason S, et al. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson’s disease. Mov disord. 2010;25(11):1652–9.
Goetz CG, Stebbins GT, Wolff D, DeLeeuw W, Bronte-Stewart H, Elble R, et al. Testing objective measures of motor impairment in early Parkinson’s disease: Feasibility study of an at-home testing device. Mov disord. 2009;24(4):551–6.
ITU. Measuring the Information Society 2013. Geneva: International Telecommunication Union, 2013. http://www.itu.int/en/ITU-D/Statistics/Documents/publications/mis2013/MIS2013_without_Annex_4.pdf. Accessed 18 Aug 2014.
Institute of Medicine (U.S.). Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, D.C.: National Academy Press; 2001. xx, 337 pp.
Dorsey ER, Venkataraman V, Grana MJ, Bull MT, George BP, Boyd CM, et al. Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA Neurol. 2013;70(5):565–70.
Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384–6.
Dorsey ER, George BP, Leff B, Willis AW. The coming crisis: obtaining care for the growing burden of neurodegenerative conditions. Neurology. 2013; 80(21):1989–96.
Willis AW, Schootman M, Evanoff BA, Perlmutter JS, Racette BA. Neurologist care in Parkinson disease: a utilization, outcomes, and survival study. Neurology. 2011;77(9):851–7.
Kumar S, Merchant S, Reynolds R. Tele-ICU: efficacy and cost-effectiveness approach of remotely managing the critical care. Open Med Inform J. 2013;7:24–9.
Kulcsar M, Gilchrist S, George MG. Improving stroke outcomes in rural areas through telestroke programs: an examination of barriers, facilitators, and state policies. Telemed J E Health. 2014;20(1):3–10.
Aita MC, Nguyen K, Bacon R, Capuzzi KM. Obstacles and solutions in the implementation of telestroke: billing, licensing, and legislation. Stroke. 2013;44(12):3602–6.
Sapirstein A, Lone N, Latif A, Fackler J, Pronovost PJ. Tele ICU: paradox or panacea? Best Pract Res Clin Anaesthesiol. 2009;23(1):115–26.
Factor SA, Feustel PJ, Friedman JH, Comella CL, Goetz CG, Kurlan R, et al. Longitudinal outcome of Parkinson’s disease patients with psychosis. Neurology. 2003;60(11):1756–61.
Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–76.
Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol. 2011;10(8):734–44.
Hubble JP. Interactive video conferencing and Parkinson’s disease. J Kans Med Soc. 1992;93(12):351–2.
Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427–42.
Parkinson’s Disease Foundation (U.S.). Recent developments in Parkinson’s disease. New York: Raven Press; 1986. pp. 153–63, 293–304.
Biglan KM, Voss TS, Deuel LM, Miller D, Eason S, Fagnano M, et al. Telemedicine for the care of nursing home residents with Parkinson’s disease. Mov Disord. 2009;24(7):1073–6.
Achey M, Aldred JL, Aljehani N, Bloem BR, Biglan KM, Chan P, et al. The past, present, and future of telemedicine for Parkinson’s disease. Mov Disord. 2014;29(7):871–83.
van der Marck MA, Bloem BR, Borm GF, Overeem S, Munneke M, Guttman M. Effectiveness of multidisciplinary care for Parkinson’s disease: a randomized, controlled trial. Mov Disord. 2013;28(5):605–11.
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.
Abdolahi A, Scoglio N, Killoran A, Dorsey ER, Biglan KM. Potential reliability and validity of a modified version of the Unified Parkinson’s Disease Rating Scale that could be administered remotely. Parkinsonism Rel Disord. 2013;19(2):218–21.
Kerr GK, Worringham CJ, Cole MH, Lacherez PF, Wood JM, Silburn PA. Predictors of future falls in Parkinson disease. Neurology. 2010;75(2):116–24.
Venkataraman V, Donohue SJ, Biglan KM, Wicks P, Dorsey ER. Virtual visits for Parkinson disease: a case series. Neurol Clin Pract. 2014;4(2):146–52.
Shprecher D, Noyes K, Biglan K, Wang D, Dorsey ER, Kurlan R, et al. Willingness of Parkinson’s disease patients to participate in research using internet-based technology. Telemed J E Health. 2012;18(9):684–7.
Brown EM. The Ontario Telemedicine Network: a case report. Telemed J E Health. 2013;19(5):373–6.
Pearl R. Kaiser Permanente Northern California: current experiences with internet, mobile, and video technologies. Health Aff. 2014;33(2):251–7.
NCSL. State Coverage for Telehealth Services: National Conference of State Legislatures; 2014. http://www.ncsl.org/research/health/state-coverage-for-telehealth-services.aspx. Accessed 18 Aug 2014
Institute of Medicine Board on Health Care Services. The role of Telehealth in an evolving health care environment: Workshop Summary. Washington, DC: National Academies Press (US); 2012.
FSMB. Telemedicine Overview: Board-by-board approach. Federation of State Medical Boards, 2013. http://library.fsmb.org/pdf/grpol_telemedicine_licensure.pdf. Accessed 18 Aug 2014.
Steinbrook R. Interstate medical licensure: major reform of licensing to encourage medical practice in multiple states. JAMA. 2014;312(7):695–96.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Harris, D., Dorsey, E. (2015). Telemedicine and Parkinson’s Disease. In: Tsao, J., Demaerschalk, B. (eds) Teleneurology in Practice. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2349-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2349-6_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2348-9
Online ISBN: 978-1-4939-2349-6
eBook Packages: MedicineMedicine (R0)